166 related articles for article (PubMed ID: 38264503)
1. Jaundice-predominant manifestation of Kawasaki disease in children.
Huang YN; Lin CY; Chi H; Chiu NC; Huang DT; Chang L; Kung YH; Huang CY
Front Pediatr; 2023; 11():1281909. PubMed ID: 38264503
[TBL] [Abstract][Full Text] [Related]
2. Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.
Yang P; Mao Z; Sun M; Guo J
Eur J Pediatr; 2023 Sep; 182(9):4049-4057. PubMed ID: 37394531
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease at British Columbia's Children's Hospital.
Ebbeson RL; Riley MR; Potts JE; Human DG; Malleson PN
Paediatr Child Health; 2004 Sep; 9(7):466-70. PubMed ID: 19657410
[TBL] [Abstract][Full Text] [Related]
4. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki Disease with Hepatobiliary Manifestations.
Suhaini SA; Azidin AH; Cheah CS; Lee Wei Li W; Khoo MS; Ismail NAS; Ali A
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557034
[No Abstract] [Full Text] [Related]
6. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
7. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
8. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
[TBL] [Abstract][Full Text] [Related]
9. Kawasaki Disease With Combined Cholestatic Hepatitis and
Huang SW; Lin SC; Chen SY; Hsieh KS
Front Pediatr; 2021; 9():738215. PubMed ID: 35223706
[TBL] [Abstract][Full Text] [Related]
10. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[TBL] [Abstract][Full Text] [Related]
11. Atypical Kawasaki Disease Complicated With Coronary Artery Aneurysm: A Case Report and Review of Literature.
Tanti SK; Mishra S
Cureus; 2021 Feb; 13(2):e13589. PubMed ID: 33815991
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study.
Liu J; Huang Y; Chen C; Su D; Qin S; Pang Y
Front Pediatr; 2022; 10():812644. PubMed ID: 35515347
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H
JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166
[TBL] [Abstract][Full Text] [Related]
14. Kawasaki disease: a comprehensive review of treatment options.
Patel RM; Shulman ST
J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
[TBL] [Abstract][Full Text] [Related]
16. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
Chen S; Dong Y; Kiuchi MG; Wang J; Li R; Ling Z; Zhou T; Wang Z; Martinek M; Pürerfellner H; Liu S; Krucoff MW
JAMA Pediatr; 2016 Dec; 170(12):1156-1163. PubMed ID: 27749951
[TBL] [Abstract][Full Text] [Related]
17. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC; Corsello G; Prinzi E; Cimaz R
Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
[TBL] [Abstract][Full Text] [Related]
18. Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature.
Pratap K; Gardner LS; Gillis D; Newman M; Wainwright D; Prentice R
BMC Gastroenterol; 2020 Oct; 20(1):352. PubMed ID: 33109118
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days.
Hu YC; Liu HM; Lin MT; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
Front Pediatr; 2019; 7():158. PubMed ID: 31069204
[No Abstract] [Full Text] [Related]
20. A Case of Kawasaki Disease with Coronary Aneurysm Responding to the 4th IVIG Treatment.
Kim JY; Kim HJ
Case Rep Cardiol; 2014; 2014():821812. PubMed ID: 25161773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
